Arif Atahan Çağatay

Author

Arif Atahan Çağatay

Also Known As

A A Cagatay, A Atahan Caĝatay, A Atahan Çağatay, A Cagatay, A. Atahan Cagatay, A. Atahan Çağatay, A. Cagatay, A. Çagatay, A. Çağatay, A. Çaǧatay

Publications

912

Citations

H-Index

Concepts

All Affiliations

Istanbul University Mersin Üniversitesi Gazi University Turkish Armed Forces Istanbul University-Cerrahpaşa

About

Arif Atahan Çağatay is an author at Istanbul University specializing in medicine, infection control, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	499
2	Health Sciences	1	1	223
3	Public Health	1	1	49
4	Diabetes	1	1	49
5	Emergency Medicine	1	1	10

Arif Atahan Çağatay

Publications

835

Citations

H-Index

Page 1

	Year	Citations
Spread of OXA-48-Positive Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Isolates in Istanbul, Turkey Amélie Carrër, Laurent Poirel, Haluk Eraksoy, Antimicrobial Agents and Chemotherapy Antimicrobial Resistance GeneAntimicrobial SusceptibilityFirst OutbreakAntibioticsHealth Sciences	2008	223
Headache characteristics in COVID-19 pandemic-a survey study Özge Uygun, Mustafa Ertaş, Esme Ekizoğlu, The Journal of Headache and Pain	2020	146
Extrapulmonary tuberculosis in immunocompetent adults Arif Atahan Çağatay, Yaşar Çalışkan, Selçuk Aksöz, Scandinavian Journal of Infectious Diseases Pulmonary TuberculosisExtrapulmonary TuberculosisPulmonary PathologyClinical EpidemiologyPathology	2004	65
The characteristics of infections in crush syndrome Arif Atahan Çağatay, Semra Çalangu, Didem Korular, Clinical Microbiology and Infection PathogenesisLymphatic FilariasisCrush SyndromeInfection ControlMedicine	2002	64
Predictors for limb loss among patient with diabetic foot infections: an observational retrospective multicentric study in Turkey Neşe Saltoğlu, Mücahit Yemişen, Önder Ergönül, Clinical Microbiology and Infection Pathogenic MicrobiologyMajor AmputationsDermatologyBacterial PathogensLimb Loss	2015	49
Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial Kathleen M. Mullane, Vicki A. Morrison, Luis H. Camacho, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccine DevelopmentImmunologyVaccine Efficacy	2019	35
Tuberculous meningitis in adults - experience from Turkey Arif Atahan Çağatay, Halit Özsüt, Leyla Gulec, International Journal of Clinical Practice	2004	30
Risk factors for mortality in patients with nosocomial Gram-negative rod bacteremia. Ceren Karakoç, Recep Tekin, Zühal Yeşilbağ, PubMed	2013	30
Community-acquired acute bacterial meningitis in the elderly in Turkey Hakan Erdem, Ömer Çoşkun, Yasemin Ersoy, Clinical Microbiology and Infection Healthcare-associated InfectionInfection ControlBacterial MeningitisMedicineClinical Microbiology	2009	26
Surveillance of Antimicrobial Resistance in Gram-Negative Isolates from Intensive Care Units in Turkey: Analysis of Data from the Last 5 Years Hakan Leblebicioğlu, Şaban Esen, İnci Tuncer, Journal of Chemotherapy	2002	25

Page 1